Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
|Study Number||Lead Group||Study Title||CIRB||Study Status|
|ACCL1034||COG||Impact of Cleansing with Chlorhexidine Gluconate (CHG) on Reducing Central Line Associated Bloodstream Infection (CLABSI) and Acquisition of Multi-drug Resistant Organisms (MDRO) in Children with Cancer or Those Receiving Allogeneic Hematopoietic Cell Transplantation (HCT): A Limited Phase III Study||Pediatric CIRB||Available to Open|
|APEC1621-MASTER||COG||NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Study||Pediatric CIRB||Available to Open|
|ADVL1622||COG||Phase 2 Trial of XL184 (Cabozantinib); an Oral Small-Molecule Inhibitor of Multiple Kinases; in Children and Young Adults with Refractory Sarcomas; Wilms Tumor; and Other Rare Tumors||Pediatric CIRB||Available to Open|
|ACCL05C1||COG||A Group-Wide; Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy||Pediatric CIRB||Completed|
|ARST0531||COG||Randomized Study of Vincristine; Dactinomycin and Cyclophosphamide (VAC) versus VAC Alternating with Vincristine and Irinotecan (VI) for Patients with Intermediate-Risk Rhabdomyosarcoma (RMS): A Groupwide Phase III Study||Pediatric CIRB||Available to Open|
|AHOD1221||COG||A Phase 1/2 Study of Brentuximab Vedotin (SGN35; IND# 117117) in Combination with Gemcitabine for Pediatric and Young Adult Patients with Relapsed or Refractory Hodgkin Lymphoma||Pediatric CIRB||Available to Open|
|NWU2014-04-01||CLO-Northwestern University||Statin Therapy to Reduce the Risk of Recurrent Pancreatitis||Cancer Prevention and Control CIRB||Available to Open|
|MAY2016-07-01||CLO-Mayo Clinic||Phase II Trial of Weekly Erlotinib Dosing to Reduce Duodenal Polyp Burden Associated with Familial Adenomatous Polyposis||Cancer Prevention and Control CIRB||Available to Open|
|NRG-CC003||NRG||Randomized Phase II/III Trial of Prophylactic Cranial Irradiation with Or without Hippocampal Avoidance for Small Cell Lung Cancer||Cancer Prevention and Control CIRB||Available to Open|
|MDA2017-09-03||CLO-MD Anderson||Pilot Study of Denosumab in BRCA1/2 Mutation Carriers scheduled for Risk-reducing Salpingooophorectomy||Cancer Prevention and Control CIRB||Available to Open|